Electromedical Technologies, Inc Income Statement
EMED|4 years of annual SEC 10-K data (FY2020-FY2023)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$1M
FY2023
Gross Profit
$1M
77.5% gross margin
Operating Income
-$2M
FY2023
Net Income
-$3M
FY2023
Electromedical Technologies, Inc reported $1M in revenue and $3M in net loss for FY2023. Revenue has grown at a 22.3% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -40.98 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | $1.3M | $1.1M | $907.4K | $738.0K |
| Cost of Revenue | $303.3K | $261.2K | $199.2K | $194.4K |
| Gross Profit | $1.0M | $888.6K | $708.1K | $543.6K |
| SG&A Expense | $3.1M | $2.5M | $4.5M | $3.7M |
| R&D Expense | $231.4K | $92.3K | $215.3K | $31.6K |
| Operating Income | -$2.1M | -$1.6M | -$3.8M | -$3.2M |
| Interest Expense | $893.2K | $791.1K | $3.3M | $769.6K |
| Net Income | -$2.6M | -$3.5M | -$8.5M | -$3.9M |
| EPS (Basic) | -$0.03 | -$0.24 | -$0.20 | - |
| EPS (Diluted) | -$0.03 | -$0.24 | -$0.20 | -$0.10 |
| Shares Outstanding | 189.8M | 87.7M | 27.2M | 17.9M |
| Gross Margin | 77.5% | 77.3% | 78.0% | 73.7% |
| Operating Margin | -153.1% | -139.5% | -418.8% | -429.1% |
| Profit Margin | -195.8% | -301.7% | -934.6% | -524.6% |